Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) EBT (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of EBT data on record, last reported at $414.1 million in Q4 2025.

  • For Q4 2025, EBT fell 17.85% year-over-year to $414.1 million; the TTM value through Dec 2025 reached $1.2 billion, up 430.28%, while the annual FY2025 figure was $1.2 billion, 430.28% up from the prior year.
  • EBT reached $414.1 million in Q4 2025 per PTCT's latest filing, up from -$23.1 million in the prior quarter.
  • Across five years, EBT topped out at $929.8 million in Q1 2025 and bottomed at -$237.5 million in Q2 2023.
  • Average EBT over 5 years is $13.7 million, with a median of -$119.9 million recorded in 2021.
  • Peak YoY movement for EBT: plummeted 181.96% in 2021, then surged 1197.84% in 2025.
  • A 5-year view of EBT shows it stood at -$138.6 million in 2021, then soared by 389.62% to $401.4 million in 2022, then plummeted by 139.12% to -$157.1 million in 2023, then soared by 420.98% to $504.1 million in 2024, then decreased by 17.85% to $414.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $414.1 million in Q4 2025, -$23.1 million in Q3 2025, and -$71.1 million in Q2 2025.